Comparison of clinical characteristics and outcomes between combined pulmonary fibrosis and emphysema associated with usual interstitial pneumonia pattern and non-usual interstitial pneumonia

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 32, Issue 2, 2015, Pages 129-137

  Sugino, Keishi ^a   Nakamura, Yasuhiko ^a   Ito, Takafumi ^a   Isshiki, Takuma ^a   Sakamoto, Susumu ^a   Homma, Sakae ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

Author keywords

Acute exacerbation; Combined pulmonary fibrosis and emphysema; Composite physiologic index; Idiopathic pulmonary fibrosis; Non usual interstitial pneumonia; Usual interstitial pneumonia

Indexed keywords

AGED; ARTICLE; CANCER INCIDENCE; CLINICAL FEATURE; COHORT ANALYSIS; COMBINED PULMONARY FIBROSIS AND EMPHYSEMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HUMAN; IMAGE ANALYSIS; INTERSTITIAL PNEUMONIA; LUNG CANCER; LUNG EMPHYSEMA; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON USUAL INTERSTITIAL PNEUMONIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; USUAL INTERSTITIAL PNEUMONIA; AREA UNDER THE CURVE; BLOOD; CAUSE OF DEATH; COMORBIDITY; COMPARATIVE STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; JAPAN; KAPLAN MEIER METHOD; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PULMONARY FIBROSIS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; VITAL CAPACITY;

BIOLOGICAL MARKER; MUC1 PROTEIN, HUMAN; MUCIN 1;

AGED; AREA UNDER CURVE; BIOMARKERS; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MUCIN-1; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 84938579297     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Cottin V, Nunes H, Brillet PY, et al. Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P): Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: A distinct underrecognised entity. Eur Respir J 2005; 26: 586-93.
2. Akagi T, Matsumoto T, Harada T, et al. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med 2009; 103: 1209-15.
3. Kurashima K, Takayanagi N, Tsuchiya N, et al. The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis. Respirology 2010; 15: 843-8.
4. Mejia M, Carrillo G, Rojas-Serrano J, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136: 10-5.
5. Kishaba T, Shimaoka Y, Fukuyama H, et al. A cohort study of mortality predictors and characteristics of patients with combined pulmonary fibrosis and emphysema. BMJ Open 2012; May 15; 2(3). pii: e000988. doi: 10. 1136/bmjopen-2012-000988.
6. Ryerson CJ, Hartman T, Elicker BM, et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest 2013; 144: 234-40.
7. Sugino K, Ota H, Fukasawa Y, Uekusa T, Homma S. Pathological characteristics in idiopathic nonspecific interstitial pneumonia with emphysema and pulmonary hypertension. Respirology Case Reports 2013; 1: 39-42.
8. Todd NW, Jeudy J, Lavania S, et al. Centrilobular emphysema combined with pulmonary fibrosis results in improved survival. Fibrogenesis Tissue Repair 2011; 4: 6. doi: 10. 1186/1755-1536-4-6.
9. Sugino K, Ishida F, Kikuchi N, et al. Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone. Respirology 2014; 19: 239-45.
10. Raghu G, Collard HR, Egan JJ, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
11. Collard HR, Moore BB, Flaherty KR, et al.; Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007; 176: 636-43.
12. Sumikawa H, Johkoh T, Colby TV, et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med 2008; 177: 433-9.
13. Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: A composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003; 167: 962-9.
14. Washko GR, Hunninghake GM, Fernandez IE, et al.; COPDGene Investigators. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011; 364: 897-906.
15. Copley SJ, Lee YC, Hansell DM, et al. Asbestos-induced and smoking-related disease: Apportioning pulmonary function deficit by using thin-section CT. Radiology 2007; 242: 258-66.
16. Cottin V, Reix P, Khouatra C, Thivolet-Bejui F, Feldmann D, Cordier JF. Combined pulmonary fibrosis and emphysema syndrome associated with familial SFTPC mutation. Thorax 2011; 66: 918-9.
17. Epaud R, Delestrain C, Louha M, Simon S, Fanen P, Tazi A. Combined pulmonary fibrosis and semphysema syndrome associated with ABCA3 mutations. Eur Respir J 2013; Oct 17. [Epub ahead of print]
18. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: The value of high resolution computed tomography in assessment. Respir Med 1990; 84: 365-9.
19. Homma Y, Saiki S, Doi O, Yoneda R, Mikami R, Tamura M. Clinical criteria for definition of idiopathic interstitial pneumonia (IIP). Nihon Kyobu Shikkan Gakkai Zasshi 1992; 30: 1371-7 (Japanese).
20. Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: The prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003; 168: 531-7.
21. Schmidt SL, Nambiar AM, Tayob N, et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J 2011; 38: 176-83.
22. Travis WD, Costabel U, Hansell DM, et al.; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733-48.